EU MDR Harmonised Standards: Complete 2026 List, GSPR Mapping, and Presumption of Conformity Guide
How harmonised standards work under EU MDR Article 8 — the complete 2026 list including Implementing Decision (EU) 2026/193, presumption of conformity mechanics, GSPR mapping methodology, the 17% harmonisation gap (48 of 277 standards), MDCG 2021-5 guidance, and practical compliance strategies for manufacturers facing the 79% regulatory grey zone.
The Harmonisation Gap Is the Biggest Compliance Challenge You Haven't Addressed
As of January 2026, only 48 of the 277 standards requested for harmonisation under the EU Medical Device Regulation have been published in the Official Journal of the European Union. That is 17%. The remaining 83% — covering everything from software lifecycle processes to biocompatibility testing to sterilization validation — exist in a regulatory grey zone where manufacturers must demonstrate compliance with the General Safety and Performance Requirements (GSPR) without the benefit of a presumption of conformity.
The situation is improving. The European Commission published Implementing Decision (EU) 2026/193 on January 30, 2026, adding twelve new standards to the harmonised list. Three more were added in April 2026. But the pace of harmonisation remains far behind the original standardisation request timeline, and the gap between what Notified Bodies expect and what has been officially harmonised continues to create compliance uncertainty.
This guide covers everything manufacturers need to know about harmonised standards under the MDR: the legal framework, how presumption of conformity works, the complete 2026 list, GSPR mapping methodology, the standardisation request process, how to handle non-harmonised standards, and practical strategies for navigating the gap.
What Are Harmonised Standards?
Harmonised standards are European standards developed by CEN (European Committee for Standardization), CENELEC (European Committee for Electrotechnical Standardization), and ETSI (European Telecommunications Standards Institute) on the basis of a standardisation request (mandate) issued by the European Commission. Once their references are published in the Official Journal of the European Union (OJEU), voluntary use of these standards confers presumption of conformity with the MDR requirements they aim to cover.
The key principles:
- Use is voluntary: Manufacturers are never legally required to use harmonised standards. You can demonstrate GSPR compliance through other means.
- Presumption of conformity is automatic: If you apply a harmonised standard within its scope and as specified, you are presumed to comply with the GSPR clauses it covers.
- Partial application is possible: You can use some harmonised standards and demonstrate compliance with other GSPR requirements through alternative evidence.
- Standards have Annex Z: Each harmonised standard contains an informative annex (typically Annex Z) that maps standard clauses to specific GSPR requirements, showing exactly which GSPR elements are covered.
Legal Basis: Article 8 of the MDR
Article 8 establishes the relationship between harmonised standards and the MDR:
Paragraph 1 — Presumption of Conformity
Devices which are in conformity with the relevant harmonised standards, or the relevant parts of those standards, the references of which have been published in the OJEU, shall be presumed to be in conformity with the requirements of the MDR covered by those standards or parts thereof.
Paragraph 2 — Partial Coverage
The Commission may publish references to harmonised standards that cover only some of the requirements of the MDR. In this case, manufacturers must demonstrate compliance with the non-covered requirements through other means.
Paragraph 3 — Withdrawal
The Commission may request that a standardisation organisation amend, maintain, or withdraw a harmonised standard if it no longer meets the requirements for presumption of conformity.
The Standardisation Request: M/575
The European Commission issued standardisation request M/575 to CEN and CENELEC on April 14, 2021, requesting the development and harmonisation of over 250 standards in support of the MDR and IVDR. The request has been amended twice:
- M/575 Amd 1 (January 31, 2023): Additional standards added
- M/575 Amd 2 (May 27, 2024): Further additions and modifications
A consolidated version of M/575 is available on the European Commission's eNorm Platform. The deadline for completion of most standards was originally October 2024, later extended to May 2028.
The Numbers (January 2026)
| Metric | MDR | IVDR | Total |
|---|---|---|---|
| Standards requested for harmonisation | 277 | 49 | 326 |
| Standards harmonised (published in OJEU) | 48 | ~15 | ~63 |
| Harmonisation rate | 17% | 31% | 19% |
| Standards in "regulatory grey zone" | 229 | ~34 | ~263 |
The Complete 2026 List of Harmonised Standards Under the MDR
The harmonised standards are published across multiple implementing decisions. The most recent updates include:
Implementing Decision (EU) 2026/193 — Published January 30, 2026
This decision added twelve new standards:
| Standard Reference | Title | GSPR Coverage |
|---|---|---|
| EN ISO 7197:2024 | Neurosurgical implants — Hydrocephalus shunts | GSPR 10-12 (implant-specific requirements) |
| EN ISO 10993-4:2017/A1:2025 | Biological evaluation — Interactions with blood | GSPR 11 (chemical, physical, biological properties) |
| EN ISO 14155:2020/A11:2024 | Clinical investigation — Good clinical practice | GSPR 1-2 (clinical evidence requirements) |
| EN ISO 14630:2024 | Non-active surgical implants — General requirements | GSPR 10-13 (implant requirements) |
| EN ISO 21535:2024 | Non-active surgical implants — Hip-joint replacements | GSPR 10-13 |
| EN ISO 21536:2024 | Non-active surgical implants — Knee-joint replacements | GSPR 10-13 |
| EN ISO 17665:2024 | Sterilization of healthcare products — Moist heat | GSPR 11, 13 (sterilization, infection control) |
| EN ISO 18562-1:2024 | Biocompatibility of breathing gas pathways — General | GSPR 11 |
| EN ISO 18562-2:2024 | Breathing gas pathways — Particulate matter tests | GSPR 11 |
| EN ISO 18562-3:2024 | Breathing gas pathways — VOC emission tests | GSPR 11 |
| EN ISO 18562-4:2024 | Breathing gas pathways — Condensate leachables | GSPR 11 |
| EN ISO 80369-2:2024 | Small-bore connectors — Respiratory applications | GSPR 11, 14 |
April 2026 Additions
Three additional standards were harmonised in April 2026:
| Standard Reference | Title |
|---|---|
| EN 13060:2025 | Sterilizers for medical purposes — Small steam sterilizers |
| EN 14222:2021+A1:2025 | Stainless steel steam boilers |
| EN IEC 60118-0:2024 | Electroacoustics — Hearing aids — Measurement of performance characteristics |
Previously Harmonised Standards (Key References)
| Standard Reference | Title | GSPR Mapping |
|---|---|---|
| EN ISO 13485:2016/A11:2021 | Medical devices — Quality management systems | Art. 10(9) QMS obligations |
| EN ISO 14971:2019/A11:2021 | Medical devices — Risk management | GSPR 1-3 (risk management) |
| EN ISO 15223-1:2021 | Medical device symbols — Labeling | GSPR 21-23 (labeling, IFU) |
| EN ISO 17664-1:2021 | Processing of medical devices — Information for reprocessing | GSPR 11, 13 |
| EN ISO 14160:2021 | Sterilization — Liquid chemical agents | GSPR 11, 13 |
| EN 13795-2:2025 | Surgical clothing and drapes — Requirements and test methods | GSPR 11, 13 |
| EN 14683:2025 | Medical face masks — Requirements and test methods | GSPR 11 |
| EN 14180:2025 | Sterilizers — Low temperature steam and formaldehyde | GSPR 11, 13 |
| EN ISO 10993-1:2021 | Biological evaluation of medical devices | GSPR 11 |
| EN ISO 10993-5:2009 | Biological evaluation — In vitro cytotoxicity | GSPR 11 |
| EN ISO 10993-7:2008 | Biological evaluation — Ethylene oxide sterilization residuals | GSPR 11 |
Critical Standards NOT Yet Harmonised (as of April 2026)
These widely-used standards have NOT been published in the OJEU and do NOT carry presumption of conformity under the MDR:
| Standard | Status | Impact |
|---|---|---|
| IEC 62304 (Medical device software lifecycle) | Not harmonised under MDR | SaMD manufacturers must independently demonstrate compliance |
| IEC 62366-1 (Usability engineering) | Not harmonised under MDR | Usability evidence must be independently justified |
| IEC 60601-1 series (Medical electrical equipment) | Partially harmonised (older versions only) | Many Part 2 particular standards not harmonised |
| ISO 11607 (Packaging validation) | Not harmonised under MDR | Packaging compliance must be independently demonstrated |
| ISO 11137 (Radiation sterilization) | Not harmonised under MDR | Sterilization validation without presumption of conformity |
| ISO 10993-1:2021 (latest revision) | Harmonised | But many sub-parts remain non-harmonised |
| ISO 13408 (Aseptic processing) | Partially harmonised (Part 1 only) | Aseptic manufacturing without full presumption |
GSPR Mapping: How to Build Your Compliance Matrix
Every manufacturer must create a compliance matrix mapping each GSPR clause to the evidence demonstrating compliance. Here is how to structure it when using harmonised standards:
Step 1: List All Applicable GSPR Clauses
MDR Annex I contains 23 GSPR clauses organized in three chapters:
- Chapter I: General requirements (GSPR 1-10) — Risk management, benefit-risk, clinical evidence, pharmaceutical substances, biological safety
- Chapter II: Design and manufacture (GSPR 11-14) — Chemical/physical/biological properties, infection control, environmental properties
- Chapter III: Information supplied with the device (GSPR 15-23) — Labeling, IFU, patient identification
Step 2: Map Standards to GSPR Clauses
For each GSPR clause, determine which harmonised standard(s) provide presumption of conformity:
| GSPR Clause | Topic | Key Harmonised Standard(s) |
|---|---|---|
| GSPR 1-3 | Risk management, benefit-risk | EN ISO 14971:2019 |
| GSPR 4 | Pharmaceuticals / human blood derivatives | None harmonised |
| GSPR 5 | Substances / CMR / endocrine disruptors | None harmonised |
| GSPR 6-7 | Biological safety, infection | EN ISO 10993 series (partial) |
| GSPR 8 | Construction / environment | None harmonised |
| GSPR 9 | Devices for disabled persons | None harmonised |
| GSPR 10 | Active devices / radiation | EN 60601 series (partial) |
| GSPR 11 | Chemical, physical, biological properties | EN ISO 10993 series, EN ISO 17665 |
| GSPR 12 | Devices connected to or combining | None harmonised |
| GSPR 13 | Materials / infection control / sterilization | EN ISO 17665, EN ISO 14160 |
| GSPR 14 | Environmental / disposal | None harmonised |
| GSPR 15-17 | Labeling, UDI | EN ISO 15223-1 |
| GSPR 18-20 | IFU requirements | None harmonised |
| GSPR 21-23 | Patient identification, implant card | EN ISO 15223-1 (symbols) |
Step 3: Document Compliance or Justification
For each GSPR clause:
- If a harmonised standard covers it: Document that you have applied the standard within its scope. The presumption of conformity applies automatically.
- If no harmonised standard covers it: Document your alternative evidence — test reports, literature, risk analysis, clinical data, or other technical justification.
- If a standard exists but is not harmonised: You may still use it as evidence of best practice, but you must independently demonstrate that it achieves the required level of safety. The presumption of conformity does not apply.
The "State of the Art" Problem
One of the most challenging aspects of the harmonisation gap is the concept of "state of the art" (SOTA). The MDR requires devices to conform to the state of the art, and harmonised standards are considered to represent the state of the art at the time of their publication. But when a standard is not harmonised:
- Notified Bodies may still expect you to follow the latest version of a non-harmonised standard as representing the state of the art
- You cannot claim presumption of conformity, even if you fully comply with the standard
- You must provide additional evidence that your approach meets the GSPR requirements
- The Notified Body has more discretion in assessing your compliance
This creates an asymmetric burden: manufacturers who follow non-harmonised standards must invest more documentation effort to prove what harmonised standard users get automatically.
Practical Compliance Strategies
Strategy 1: Prioritise Harmonised Standards
Where a harmonised standard exists for your device type, use it. This is the path of least resistance. Notified Bodies generally expect manufacturers to apply relevant harmonised standards, and the presumption of conformity significantly reduces review time and back-and-forth queries.
Strategy 2: Build Robust Alternative Evidence for Non-Harmonised GSPR Clauses
For GSPR clauses where no harmonised standard exists, develop comprehensive evidence packages:
- Internal test protocols and reports
- Literature reviews demonstrating safety and performance
- Risk analyses specifically addressing the GSPR requirement
- Comparison with predicate devices using the same technology
Strategy 3: Monitor OJEU Publications
The harmonisation list is updated multiple times per year. Implement a regulatory intelligence process to track new publications:
- January 2026: Implementing Decision (EU) 2026/193 (12 new standards)
- April 2026: Three additional standards (sterilizers, steam boilers, hearing aids)
- Next expected update: Mid-2026
Strategy 4: Use MDCG Guidance Documents
When standards are not harmonised, MDCG guidance documents provide the next best source of compliance direction:
- MDCG 2021-5 rev.1: Guidance on standardisation for medical devices
- MDCG 2020-1: Clinical evaluation guidance
- MDCG 2020-5: Clinical evaluation of equivalence
Strategy 5: Track Standard Versions
When a harmonised standard references a specific version (e.g., EN ISO 14971:2019/A11:2021), you must use that version to claim presumption of conformity. Using a newer version that has not yet been harmonised means you lose the presumption. Maintain a register of:
- Which version is harmonised
- Which version you are using
- Whether you are claiming presumption of conformity or alternative compliance
The IEC/CEN Court Case: A 2026 Development
A significant development in 2026 is the ongoing ISO/IEC court case that could affect the future of standardisation in Europe. The case relates to copyright restrictions on referencing ISO/IEC standards in European harmonisation processes. If resolved in a way that restricts CEN/CENELEC's ability to adopt ISO/IEC standards, it could further slow the harmonisation pace under the MDR. The MDCG Standards Working Group is actively monitoring this situation.
Harmonised Standards and the 2025 Simplification Proposal
The December 2025 MDR/IVDR simplification proposal (COM(2025)1023) does not directly change the harmonised standards framework. However, it does propose:
- Broader acceptance of non-clinical data for demonstrating safety and performance
- Greater flexibility in clinical evidence approaches
- Potential for faster adoption of standards through streamlined processes
These proposals are under legislative review and have not been adopted as of April 2026.
Frequently Asked Questions
What does "presumption of conformity" actually mean?
It means that if you correctly apply a harmonised standard within its specified scope, Notified Bodies and Competent Authorities must accept that you comply with the GSPR clauses covered by that standard. They cannot require additional evidence for those specific requirements. However, the presumption only covers the GSPR elements explicitly mapped in the standard's Annex Z — it does not extend beyond the standard's scope.
Are harmonised standards mandatory?
No. The use of harmonised standards is entirely voluntary. You can demonstrate GSPR compliance through any technically valid means. However, using harmonised standards is the path of least resistance because it grants automatic presumption of conformity, which significantly simplifies the conformity assessment process.
What percentage of MDR standards have been harmonised?
As of January 2026, approximately 17% of the 277 standards requested for harmonisation under the MDR have been published in the OJEU (48 standards). For the IVDR, approximately 31% of 49 requested standards have been harmonised (~15 standards). The European Commission acknowledges this gap and continues to publish new harmonisation decisions.
What happens if a standard I use is not harmonised?
You can still use it as evidence of good practice, but you do not get presumption of conformity. You must independently demonstrate that your approach meets the applicable GSPR requirements through additional test reports, risk analyses, literature reviews, or other technical evidence. Notified Bodies will scrutinize this evidence more closely than they would a harmonised standard application.
How often is the harmonised standards list updated?
The list is updated through Commission Implementing Decisions published in the OJEU. In 2025-2026, updates occurred approximately every 3-4 months: October 2025 (Decision (EU) 2025/2078), January 2026 (Decision (EU) 2026/193), and April 2026. Manufacturers should monitor the European Commission's health portal for new publications.
Can I use a newer version of a standard than what has been harmonised?
Yes, but you lose the presumption of conformity for the differences between the harmonised version and the newer version. You must document and justify compliance with the newer version's additional or modified requirements through alternative evidence. Many manufacturers choose to apply the harmonised version for the presumption of conformity while also considering the newer version's requirements.
How do I find out which GSPR clauses a harmonised standard covers?
Each harmonised standard contains an informative annex (typically Annex Z in EN standards) that maps the standard's clauses to specific GSPR requirements. This annex shows exactly which GSPR elements are covered, giving you a clear scope of the presumption of conformity.
What is MDCG 2021-5 rev.1?
This is the MDCG guidance document on standardisation for medical devices. It explains the role of harmonised standards in the MDR framework, how presumption of conformity works, how to handle non-harmonised standards, and the concept of state of the art. It is the primary guidance document for manufacturers navigating the standards landscape.
Do I need to reference harmonised standards in my Declaration of Conformity?
Yes. Article 19 and Annex IV of the MDR require the DoC to include references to the harmonised standards that have been applied. If you have applied common specifications instead of or in addition to harmonised standards, these must also be referenced. The DoC must identify the specific standards and their version numbers.
What is the standardisation request M/575?
M/575 is the formal request issued by the European Commission to CEN and CENELEC on April 14, 2021, asking them to develop and adopt over 250 standards in support of the MDR and IVDR. The request has been amended twice (January 2023, May 2024) to expand the scope. The consolidated version is available on the eNorm Platform. The deadline for most standards is May 2028.